LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 4.36 | 84.90 | 762 | 322 | 2.3623 | 2.1252 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 4.36 | 84.90 | 778 | 322 | 2.4119 | 2.1591 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 6.06 | 84.90 | 852 | 365 | 2.3314 | 1.9894 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 6.06 | 84.90 | 831 | 365 | 2.2739 | 1.9542 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 7.77 | 84.90 | 963 | 411 | 2.3417 | 1.9065 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 7.77 | 84.90 | 919 | 411 | 2.2347 | 1.8474 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 9.47 | 84.90 | 2 | 447 | 0.0045 | -0.7905 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 9.47 | 84.90 | 1032 | 447 | 2.3065 | 1.8340 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 9.47 | 84.90 | 4 | 447 | 0.0089 | -0.7203 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 9.47 | 84.90 | 989 | 447 | 2.2104 | 1.7841 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 11.18 | 84.90 | 3 | 492 | 0.0061 | -0.7324 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 11.18 | 84.90 | 1101 | 492 | 2.2362 | 1.7470 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 11.18 | 84.90 | 14 | 492 | 0.0284 | -0.5087 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 11.18 | 84.90 | 1078 | 492 | 2.1895 | 1.7242 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 12.88 | 84.90 | 2 | 531 | 0.0038 | -0.7576 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 12.88 | 84.90 | 1142 | 531 | 2.1507 | 1.6716 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 12.88 | 84.90 | 85 | 531 | 0.1601 | 0.0005 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 12.88 | 84.90 | 1152 | 531 | 2.1695 | 1.6804 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 14.58 | 84.90 | 2 | 663 | 0.0030 | -0.7174 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 14.58 | 84.90 | 1236 | 663 | 1.8631 | 1.4668 | MN20160318_Q02 | K14 |